版本:
中国

BRIEF-Bluebird Bio provides update on Lentiglobin programs

Oct 13 Bluebird Bio Inc

* Bluebird Bio provides update on Lentiglobin programs and research and development strategy at gene therapy day

* Bluebird Bio application for conditional approval for Lentiglobin in EU would be based on data from HGB-204 and HGB-205 studies of Lentiglobin

* Bluebird Bio application for conditional approval for Lentiglobin in EU would be also be based on available data from HGB-207, HGB-212 studies Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐